Amanote Research

Amanote Research

    RegisterSign In

Discover open access scientific publications

Search, annotate, share and cite publications


Publications by Robert L. Schlossman

A Phase 1/2 Study of Evofosfamide, a Hypoxia-Activated Prodrug With or Without Bortezomib in Subjects With Relapsed/Refractory Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2018English

Patient-Reported Outcomes of Multiple Myeloma Patients Treated With Panobinostat After ≥2 Lines of Therapy Based on the International Phase 3, Randomized, Double-Blind, Placebo-Controlled PANORAMA-1 Trial

British Journal of Haematology
Hematology
2018English

The Medical Research Council Myeloma IX Trial: The Impact on Treatment Paradigms*

European Journal of Haematology
MedicineHematology
2011English

The Impact of ASCT on Patients With Newly Diagnosed Multiple Myeloma Who Receive RVD Induction

Journal of Hematological Malignancies
2013English

Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

MDM2 Protein Overexpression Promotes Proliferation and Survival of Multiple Myeloma Cells

Blood
BiochemistryImmunologyCell BiologyHematology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy